MedPageToday -- TORONTO -- The osteoporosis drug zoledronic acid (Reclast) significantly increased health-related quality of life over and above its reduction in the fracture rate, a researcher said here.
MedPageToday -- TORONTO -- The osteoporosis drug zoledronic acid (Reclast) significantly increased health-related quality of life over and above its reduction in the fracture rate, a researcher said here.